All data are based on the daily closing price as of March 20, 2026
s
Sunmax Biotechnology
4728.TWO
12.29 USD
0.11
+0.90%
Overview
Last close
12.29 usd
Market cap
669.24M usd
52 week high
16.58 usd
52 week low
7.93 usd
Target price
N/A usd
Valuation
P/E
29.4891
Forward P/E
N/A
Price/Sales
10.5503
Price/Book Value
13.2137
Enterprise Value
641.30M usd
EV/Revenue
10.1347
EV/EBITDA
18.3054
Key financials
Revenue TTM
63.28M usd
Gross Profit TTM
49.61M usd
EBITDA TTM
34.37M usd
Earnings per Share
0.42 usd
Dividend
N/A usd
Total assets
67.65M usd
Net debt
N/A usd
About
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.